Raiffeisen Bank International’s Royalty Pharma RPRX Stock Holding History

Raiffeisen Bank International’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	19,172 +758	+4%	+$39.5K	0.01%	404
2026 Q1	$854K	Sell	18,414 -44,676	-71%	-$1.96M	0.01%	403
2025 Q4	$2.46M	Buy	63,090 +24,108	+62%	+$919K	0.03%	235
2025 Q3	$1.37M	Buy	38,982 +20,982	+117%	+$760K	0.02%	282
2025 Q2	$646K	Hold	18,000	–	–	0.01%	338
2025 Q1	$565K	Sell	18,000 -2,000	-10%	-$63.4K	0.01%	356
2024 Q4	$506K	Buy	+20,000	New	+$530K	0.01%	355

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raiffeisen Bank International's RPRX Position: Q2 2026 in Review

Raiffeisen Bank International increased its Royalty Pharma (RPRX) stake by 4.1% in Q2 2026, buying an estimated $39.5K and bringing the position to 19,172 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #404.

Raiffeisen Bank International first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.46M in Q4 2025. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Raiffeisen Bank International held 19,172 shares of Royalty Pharma worth $1.09M as of Q2 2026.
Raiffeisen Bank International bought 758 Royalty Pharma shares in Q2 2026, an estimated $39.5K.
Royalty Pharma made up 0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #404 holding.
Raiffeisen Bank International first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Royalty Pharma position peaked at $2.46M in Q4 2025.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.